Normal1 A new edition of international guidelines for the treatment of sepsis has been published. Dr. Ricard Ferrer, head of the group of Shock, Organ Dysfunction and Resuscitation, is one of those responsible of their publication. Normal1 Sepsis is a disease that occurs when the patient suffers a serious infection and the immune system reacts, causing multiple organ failure. This is a serious pathology, the reaction rate is vital in its approach. Normal1 In this sense, Vall d'Hebron Campus, through the group of http://es.vhir.org/portal1/grup-equip.asp?s=recerca&contentid=187164&t=Shock,%20Disfunci%C3%B3%20Org%C3%A0nica%20i%20Ressuscitaci%C3%B3 Shock, Organ Dysfunction and Resuscitation of Vall d'Hebron Research Institute (VHIR), led by Dr. Ricard Ferrer, leads the research in this field. It counts with the first Biobank in the country and the second in Europe specific of sepsis. It aims to find markers to make the diagnosis of this pathology. Normal1 Normal1 VHIR has the first biobank of sepsis in the country. Normal1 From the biobank depend several research projects. In addition, at this time there are three clinical trials underway. The use of thrombomodulin anticoagulant is been studied, as well as the alkaline phosphatase, a kidney protector that inhibits endotoxin which is in the cell wall of bacteria. Mesenchyme cell therapy as immunomodulatory cells is also discussed and several trials with antibiotics are made. Normal1 Normal1 International guidelines and Sepsis Code Normal1 A new edition of international guidelines for the treatment of sepsis has been published. Dr. Ricard Ferrer, head of the group of Shock, Organ Dysfunction and Resuscitation, is one of those responsible of their publication. Normal1 International management guidelines, coupled with the implementation, since 2015, of the http://www.vhebron.net/es/noticies-sala-de-premsa/-/asset_publisher/u7V5/content/vall-d-hebron-posa-en-marxa-el-codi-sepsia-greu-intrahospitalari/10165,jsessionid=6ABB2B9D07D4ACA1CF4C849882E19A4D Sepsis Code, have become basic tools for health professionals at the University Hospital Vall Hebron. Their combined application has achieved a 25% reduction in mortality in these cases. Normal1 Dr. Ricard Ferrer, head of http://www.vhebron.net/es/medicina-intensiva Intensive Care at Vall d'Hebron, has been one of the authors of the latest revision of the Surviving sepsis campaign guidelines. They were published for the first time in 2002, they are an initiative of European Societies of Intensive Care Medicine and the United States, and the contents are reviewed every 4 years. Dr. Ferrer explained that "there is no new innovative treatment, but all improvements that have appeared in recent years in treatment are collected." But it does remembers the three pillars of treatment, antibiotic treatment with broad spectrum, which is to be administered before 1 hour, focus of infection control measures, surgical in many cases, and the restoration of cardiovascular status of the patient. Normal1 In Vall d'Hebron, to face it, there is the Sepsis Code, in which professionals of Intensive Care Medicine, Emergency and Microbiology work together. In 2016, 485 episodes of sepsis were activated. Normal1 Its application has standardized patient tracking, prioritizing the treatment of microbiological samples, source control, potential radiological tests and admission to the Intensive Care Unit. Dr. Ferrer recalls that "in any patient with sepsis, the Hospital has a code that must be activated and thus ensure that the patient receive early treatment as stated in the clinical guidelines."